.Amgen has shared (PDF) the very first phase 3 data on its $400 thousand chronic eczema medicine, co...
.Biogen as well as UCB's bet one's bottom dollar developing right into stage 3 on the back of a brok...
.Italian biotech Aptadir Therapies has actually launched with the assurance that its own pipeline of...
.Surge Life Sciences has actually satisfied its target in a Duchenne muscular dystrophy (DMD) resear...
.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fol...
.Achilles Rehabs has actually wrecked its method. The British biotech is actually knocking off on it...
.Aligos Therapeutics is advertising a midstage succeed in metabolic-dysfunction associated steatohep...
.Basilea Pharmaceutica's work cultivating brand new antifungals has gotten a considerable boost comi...
.Having already gathered up the U.S. civil rights to Capricor Rehabs' late-stage Duchenne muscular d...
.After pushing the choice meeting for Applied Rehabs' metabolic ailment medication govorestat, the F...